Evidence map›Paper›PMID 29087309›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Endosomal signaling of the receptor for calcitonin gene-related peptide mediates pain transmission.

Rebecca E Yarwood, Wendy L Imlach, TinaMarie Lieu, Nicholas A Veldhuis, Dane D Jensen, Carmen Klein Herenbrink, Luigi Aurelio, Zhijian Cai, MacDonald J Christie, Daniel P Poole and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 112 papers.

0numbers the graph read from it
0cells of the map it votes in
112citing papers in PubMed
8.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

112 citing papers in PubMed, 180 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Oncogenic Gα signaling requires AP-3-dependent recruitment to the endolysosomal compartment.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Review
  6. Review
  7. Review
  8. MMP1 and PRSS23 induce PARCommunications biology · 2026
    Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Mechanisms of Location Bias in G Protein-Coupled Receptors.Handbook of experimental pharmacology · 2026
    Review
  14. Article
  15. Article
  16. Nanomedicines targeting protease-activated receptor 2 in endosomes provide sustained analgesia.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  17. Emerging therapeutic approaches for treating abdominal pain.Journal of the Canadian Association of Gastroenterology · 2025
    Review
  18. PACAP versus CGRP in migraine: From mouse models to clinical translation.Cephalalgia : an international journal of headache · 2025
    Review
  19. Review
  20. Article

52 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 3 countries.

Rebecca E YarwoodMonash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia.
Wendy L ImlachMonash Biomedicine Discovery Institute, Monash University, Melbourne, VIC 3800, Australia.
TinaMarie LieuMonash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia.
Nicholas A VeldhuisMonash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia.
Dane D JensenMonash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia.
Carmen Klein HerenbrinkMonash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia.
Luigi AurelioMonash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia.
Zhijian CaiMonash Biomedicine Discovery Institute, Monash University, Melbourne, VIC 3800, Australia.
MacDonald J ChristieDiscipline of Pharmacology, University of Sydney, Sydney, NSW 2006, Australia.
Daniel P PooleMonash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia.
Christopher J H PorterMonash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia.ORCID 0000-0003-3474-7551
Peter McLeanTakeda Pharmaceuticals Inc., Cambridge, MA 02139.
Gareth A HicksTakeda Pharmaceuticals Inc., Cambridge, MA 02139.
Pierangelo GeppettiDepartment of Health Sciences, Clinical Pharmacology Unit, University of Florence, 50139 Florence, Italy.
Michelle L HallsMonash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia.
Meritxell CanalsMonash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia; meri.canals@monash.edu nb2733@cumc.columbia.edu.
Nigel W BunnettMonash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia; meri.canals@monash.edu nb2733@cumc.columbia.edu.
Australian Research Council · AUAustralian Regenerative Medicine Institute · AUTakeda (United States) · USThe University of Sydney · AUUniversity of Florence · IT

Funding

Endosomal Platforms for Signaling PainR01NS102722 · NINDS · NEW YORK UNIVERSITY · PI NIGEL W BUNNETT, Brian L Schmidt · 2017 to 2026
$3.4M
NINDS NIH HHS R01 NS102722
6 · The paper itself

Abstract

G protein-coupled receptors (GPCRs) are considered to function primarily at the plasma membrane, where they interact with extracellular ligands and couple to G proteins that transmit intracellular signals. Consequently, therapeutic drugs are designed to target GPCRs at the plasma membrane. Activated GPCRs undergo clathrin-dependent endocytosis. Whether GPCRs in endosomes control pathophysiological processes in vivo and are therapeutic targets remains uncertain. We investigated the contribution of endosomal signaling of the calcitonin receptor-like receptor (CLR) to pain transmission. Calcitonin gene-related peptide (CGRP) stimulated CLR endocytosis and activated protein kinase C (PKC) in the cytosol and extracellular signal regulated kinase (ERK) in the cytosol and nucleus. Inhibitors of clathrin and dynamin prevented CLR endocytosis and activation of cytosolic PKC and nuclear ERK, which derive from endosomal CLR. A cholestanol-conjugated antagonist, CGRP

Indexed as

Adrenergic AntagonistsAnimalsCalcitonin Gene-Related PeptideCalcitonin Receptor-Like ProteinCapsaicinCholestanolsClathrinDynaminsEndocytosisEndosomesFormaldehydeFreund's AdjuvantGene Expression RegulationInjections, SpinalMaleMiceAdrenergic AntagonistsCalcitonin Gene-Related Peptidecalcitonin gene-related peptide (8-37)Calcitonin Receptor-Like ProteinCalcrl protein, ratCapsaicinCholestanolsClathrinDynaminsFormaldehydeFreund's AdjuvantMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Peptide FragmentsProtein Kinase CendocytosisG protein-coupled receptorsneuropeptidesnociceptionpain

Identifiers

PMID29087309
PMCPMC5699040
OpenAlexW2767140579

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.